Diligence memo · auto-generated · as of July 2, 2026

ColonarySolutions, LLC

ColonarySolutions, LLC looks under-valued against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

ColonarySolutions, LLC operates in Biotechnology, based in PALM BEACH GARDENS.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

ColonarySolutions, LLC has raised $4.3M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).

Largest single filing: $2.8M on 2018-01-16.

Most recent recorded round closed around 2020-03-18.

Valuation (modeled)modeled

Provath models ColonarySolutions, LLC at approximately $8.9M (range $144K–$70M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.14× the median modeled value of Seed Biotechnology companies in 2019–2021 (186 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 5 months.

Last raise 6.3 yr ago; this sector typically re-raises about every 14 months.

Silent for over 3× the sector's normal cadence.

The last round was 5.0× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 41% of Biotechnology peers (4293 compared).

Modeled value ranks above 17% of those peers.

Closest niche peers: Novo Biosciences, Inc., Entac Medical, Inc., ReGelTec, Inc., Korro Bio, Inc., TamuroBio Inc..

Peoplefiled

6 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.